DR. GAUTAM R MOORJANI MD NPI 1780617282

NPI Details

DR. Gautam R Moorjani, MD is a rheumatology internal medicine in San Antonio, TX with 23 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Gautam R Moorjani, MD NPI is 1780617282. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: TEXAS TECH UNIVERSITY HEALTH SCIENCE CENTER SCHOOL OF MEDICINE
Graduation Year:2002

The provider's business location address is:

19272 STONE OAK PARKWAY
SUITE 101
SAN ANTONIO, TX
ZIP 78258
Phone: (210) 265-8851
Fax: (210) 265-8855

The NPI 1780617282 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Measurement of dna antibody, single stranded (HCPCS:86226)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Vitamin d-3 level (HCPCS:82306)
• Uric acid level, blood (HCPCS:84550)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Rheumatoid factor level (HCPCS:86431)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Screening test for autoimmune disorder (HCPCS:86038)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Folic acid level, serum (HCPCS:82746)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)

The enumeration date for this NPI number is 7/8/2006 and was last updated on 7/29/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.